The effect of myo-inositol and N-acetyl-L-cysteine on prepared sperms

Phase 3

• Conditions: male infertility.; Male infertility

• Registration Number: IRCT20190204042618N2
• Lead Sponsor: Shahre-kord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 23 April 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 63

Inclusion Criteria

Infertility history for at least 12 months
Infertility with male causes
Non-use of minerals, multivitamins and any fertility enhancer drug during the last three months

Exclusion Criteria

Using alcoholic drinks or Unauthorized compounds and drugs(Opiate, Psychotropic drugs, Bodybuilding compounds, Antipsychotics, Sedative)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sperm viability. Timepoint: Before the proximity to medication, at the end of the incubation period. Method of measurement: Trypan blue staining and contrast phase microscope.;Sperm morphology. Timepoint: Before the proximity to medication, at the end of the incubation period. Method of measurement: Contrast phase microscope, Sperm analyzer device.;Total sperm motility. Timepoint: Before the proximity to medication, at the end of the incubation period. Method of measurement: Contrast phase microscope, Sperm analyzer device.;SMI. Timepoint: Before the proximity to medication, at the end of the incubation period. Method of measurement: Sperm analyzer device.;PMSCa. Timepoint: Before the proximity to medication, at the end of the incubation period. Method of measurement: Contrast phase microscope, Sperm analyzer device.;PMSCb. Timepoint: Before the proximity to medication, at the end of the incubation period. Method of measurement: Contrast phase microscope, Sperm analyzer device.